L-Theanine for Dogs: How It Works and What the Evidence Says
L-theanine is a tea-derived amino acid found in many calming chews. What peer-reviewed research says about mechanism, canine-specific studies, dosing, and where the evidence gaps remain.
Published
Apr 8, 2026
Updated
Apr 8, 2026
References
5 selected
This guide contains affiliate links. If you purchase through our links, we may earn a small commission at no cost to you.
What L-theanine is and where it comes from
L-theanine (gamma-glutamylethylamide) is a non-proteinogenic amino acid found almost exclusively in the tea plant (Camellia sinensis), where it accounts for roughly 1 to 2.5 percent of dry leaf weight (Chong et al., 2025, PMCID: PMC12351064). It was first isolated from green tea in 1949 by Japanese researchers and has since become one of the most studied bioactive compounds in functional food science.
Structurally, L-theanine resembles glutamate, the brain's primary excitatory neurotransmitter. That structural similarity is the basis for most of its proposed neurological effects: it can interact with the same receptor subtypes that glutamate targets, including NMDA and AMPA receptors, but without producing the same excitatory cascade. In practical terms, this means L-theanine may modulate neural activity without acting as a sedative.
If your dog takes a calming chew containing L-theanine, what they're getting is a purified version of the same compound that gives green tea its characteristic umami flavor. The question is whether that compound, extracted from tea and formulated into a chewable supplement, produces a meaningful behavioral effect in dogs at the doses typically included in commercial products.
Key takeaway
L-theanine is a tea-derived amino acid that resembles glutamate in structure. It interacts with brain receptors involved in excitatory signaling, but does not produce sedation.
How it works in the brain
The proposed mechanism of L-theanine involves several overlapping pathways, most of which have been studied in human and rodent models rather than in dogs. A 2025 comprehensive review (Chong et al., PMCID: PMC12351064) summarizes the primary pathways as follows.
Alpha brain wave promotion
Best-documented human effect. Not yet studied in dogs.
In human EEG studies, oral L-theanine increases alpha-wave power in the frontal cortex within 30 to 60 minutes of ingestion. Alpha waves (8 to 13 Hz) are associated with a state of relaxed alertness, the kind of calm attention you might feel during meditation or focused reading. This is a fundamentally different neurological state from sedation, which is characterized by theta and delta wave dominance. The practical implication: if this effect translates to dogs, L-theanine should produce calm without drowsiness.
Glutamate modulation
Plausible mechanism, based on structural similarity.
Because L-theanine is structurally similar to glutamate, it can bind to NMDA and AMPA glutamate receptors. In rodent models, this binding appears to attenuate excessive excitatory signaling without fully blocking it. The result, at least in rodents, is a dampening of the neurochemical cascade associated with acute stress. Whether the same effect occurs in dogs at supplement-level doses has not been directly measured.
GABA and serotonin influence
Observed in rodents. Direction of effect varies by study.
Some rodent studies report that L-theanine increases GABA (gamma-aminobutyric acid, the brain's primary inhibitory neurotransmitter) while decreasing serotonin in certain brain regions. Other studies report different directional effects depending on dose, brain region, and co-administered compounds. The takeaway is that L-theanine appears to interact with inhibitory neurotransmitter systems, but the precise nature of that interaction is not yet settled even in rodent literature.
Key takeaway
L-theanine promotes alpha brain waves (relaxed alertness) in humans, modulates glutamate signaling, and interacts with GABA pathways in rodents. None of these mechanisms have been directly measured in dogs.
Wondering whether L-theanine fits your dog's specific anxiety pattern? Walk Scout through a recent episode and get a recommendation that accounts for trigger type, body weight, and what you've already tried.
What the canine studies found
This is where intellectual honesty matters most. L-theanine has a reasonable body of human research and a plausible pharmacological mechanism, but the canine-specific evidence is thin. There are a handful of published studies on L-theanine in dogs, and they have limitations worth understanding before drawing conclusions.
Pike et al. (2015): Anxitane for storm-sensitive dogs
Open-label, no placebo control. High dropout rate.
This study, reviewed in a 2023 practitioner-focused evidence summary (Riemer, PMCID: PMC10705068), enrolled 26 client-owned dogs with owner-reported thunderstorm sensitivity and treated them with Anxitane, a commercial L-theanine supplement. Owners reported a significant reduction in global anxiety scores and faster return-to-baseline after storms. However, 8 of the 26 dogs (about 31 percent) dropped out before the study concluded, which introduces a meaningful selection bias: the dogs that completed the study may have been the ones already responding. The study was also open-label, meaning both owners and investigators knew which treatment was being administered. With no placebo group and no blinding, the placebo effect (on the owner's perception of their dog's behavior) cannot be separated from any pharmacological effect.
DePorter et al. (2012): Harmonease for noise fear
Blinded, placebo-controlled. Combination product.
This laboratory-based study tested Harmonease, a chewable tablet combining L-theanine with extracts of Magnolia officinalis and Phellodendron amurense, in dogs exposed to simulated thunderstorm recordings. The study used a blinded, placebo-controlled design, which is methodologically stronger than the Pike study. Dogs receiving Harmonease showed reduced behavioral signs of fear compared to the placebo group. The limitation: because Harmonease is a multi-ingredient product, the contribution of L-theanine specifically cannot be isolated from the magnolia and phellodendron extracts, both of which have their own proposed anxiolytic properties.
Michelazzi et al. (2010): L-theanine plus behavior therapy
Conference abstract. Limited methodological detail available.
Published as a conference abstract in the Journal of Veterinary Behavior, this study reported on L-theanine combined with behavioral therapy for dogs with noise phobias. The combination was reported to improve outcomes compared to behavioral therapy alone. However, the publication format (conference abstract rather than full peer-reviewed paper) limits the depth of methodological evaluation possible, and the study has not been independently replicated in a full-length publication.
The honest summary
Promising signals, but not proof.
Across these studies, L-theanine shows a consistent directional signal: dogs receiving it tend to show less fear-related behavior than baseline or compared to untreated groups. But the evidence base is small, the study designs are mixed (only one used a placebo control, and that one tested a combination product), and no large-scale, blinded, placebo-controlled trial has tested L-theanine as a standalone ingredient in dogs. That does not mean L-theanine doesn't work. It means the current evidence is not strong enough to confirm that it does.
Key takeaway
Canine studies show a positive directional signal for L-theanine in noise-related anxiety, but sample sizes are small, designs vary, and no large-scale placebo-controlled trial has tested L-theanine alone in dogs.
L-theanine vs. alpha-casozepine: not the same thing
This distinction matters because both ingredients appear in calming supplements, both are marketed with the same broad claims, and they're sometimes confused in product reviews and consumer discussions. They are chemically and mechanistically distinct.
L-theanine
Source: tea leaves (Camellia sinensis). Structure: non-proteinogenic amino acid, glutamate analog. Primary proposed mechanism: modulates glutamate receptor activity, promotes alpha brain wave activity, interacts with GABA pathways indirectly. Does not bind directly to GABA-A benzodiazepine sites. Found in products like VetriScience Composure and Zesty Paws Calming Bites.
Alpha-casozepine
Source: tryptic hydrolysis of bovine alpha-s1 casein (milk protein). Structure: a ten-amino-acid peptide (decapeptide). Primary mechanism: binds to GABA-A receptor benzodiazepine sites, confirmed in a 2022 rat study using the antagonist flumazenil (Benoit et al., PMCID: PMC9182760). The affinity is approximately 10,000 times weaker than diazepam, which may explain why it produces anxiolytic-like effects without the sedation, tolerance, or dependence seen with benzodiazepines. Marketed as Zylkene.
The practical difference: L-theanine works primarily through glutamate modulation and alpha-wave promotion, while alpha-casozepine works through the GABA-A benzodiazepine receptor pathway. A product containing one does not deliver the mechanism of the other. Some calming chews include both, which is a reasonable formulation strategy if you accept the premise that targeting multiple pathways may be more effective than targeting one. But a label that lists “calming amino acids” without specifying which compound is present at what dose is not giving you enough information to evaluate what your dog is actually receiving. For a broader look at ingredient categories, the calming supplements guide breaks down every major ingredient category.
Key takeaway
L-theanine and alpha-casozepine are different compounds with different mechanisms. Knowing which one is in your dog's supplement matters for understanding what it might do.
Dosing, onset, and safety
Canine-specific pharmacokinetic data for L-theanine are limited. Most dosing guidance comes from extrapolation of human and rodent data, manufacturer recommendations, and clinical experience reported by veterinary behaviorists. Here is what is currently known.
Typical dosing range
Commercial L-theanine products for dogs (such as Anxitane and the L-theanine component of VetriScience Composure) generally provide between 25 mg and 200 mg per dose, tiered by body weight. Most products recommend a higher dose range for dogs over approximately 25 kg (55 lbs). These doses are derived from manufacturer protocols and clinical use patterns rather than from formal dose-response studies in dogs.
Onset timing
In human pharmacokinetic studies, L-theanine crosses the blood-brain barrier within approximately 30 to 60 minutes of oral administration, with peak plasma concentrations occurring in a similar window. Most veterinary product labels recommend giving L-theanine 30 to 60 minutes before an anticipated stressor, which aligns with the human absorption data. Some products are designed for daily administration, suggesting a cumulative-effect model, though the evidence for cumulative versus acute dosing in dogs has not been formally compared.
Safety profile
L-theanine has a favorable safety record across available studies. In the Pike et al. study, no serious adverse effects were reported in dogs receiving L-theanine (Anxitane) over the study period. L-theanine does not produce sedation at typical supplement doses, which distinguishes it from some other calming ingredients. It does not undergo hepatic cytochrome P450 metabolism to the same degree as CBD, which means the drug interaction profile is considerably more benign. That said, long-term safety studies in dogs have not been published, and any dog on concurrent medication should be evaluated by a veterinarian before adding a supplement.
What we don't know
We do not have published canine pharmacokinetic curves showing absorption rate, brain penetration, or elimination half-life. We do not know the minimum effective dose in dogs by body weight. We do not know whether daily versus situational dosing produces different outcomes. These gaps are not red flags — L-theanine has been used in veterinary products for over a decade without significant safety signals — but they do mean that dosing recommendations rest on clinical extrapolation rather than direct canine pharmacology data. If your dog is on prescription anxiety medication, a conversation with your veterinarian before adding L-theanine is the right step. For context on how CBD compares on the evidence and drug interaction front, that guide covers the pharmacokinetic picture in detail.
Key takeaway
L-theanine appears safe at typical supplement doses, with no reported serious adverse effects in canine studies. Dosing is extrapolated from human data and manufacturer protocols. Canine pharmacokinetic data are missing.
What to look for in a product
Not all calming chews that mention L-theanine deliver the same thing. The supplement market is largely self-regulated, and label practices vary from transparent to opaque. A few things to check before buying.
- Milligram-level L-theanine disclosure. The label should state how many milligrams of L-theanine are in each serving, not just that the product “contains L-theanine” as part of a proprietary blend. Without per- ingredient quantification, you cannot evaluate whether the dose is in the range used in published studies (typically 25 to 200 mg, scaled by body weight).
- Weight-based dosing guidance. A 10-pound Chihuahua and an 80-pound Labrador should not receive the same dose. Products that provide a tiered dosing chart by weight range are giving you more useful information than a flat “one chew per day” instruction.
- NASC Quality Seal. That seal is one of the faster ways to screen for a company that follows Good Manufacturing Practices, maintains accurate labeling, and participates in adverse event reporting. It is not a guarantee of efficacy, but it is a meaningful quality floor in an industry with minimal mandatory oversight.
- Know what else is in the formula. Many calming chews combine L-theanine with other ingredients: melatonin, chamomile, valerian, tryptophan, thiamine, or colostrum. That is not inherently a problem, but it means the product's observed effects (good or bad) cannot be attributed to L-theanine alone. If you want to evaluate whether L-theanine specifically helps your dog, a product with L-theanine as the primary or sole active ingredient gives you cleaner data than a ten-ingredient blend. For more on how to read calming supplement labels, the hemp vs. CBD guide untangles a similar labeling problem in another ingredient category.
Key takeaway
Look for milligram-level L-theanine disclosure, weight-based dosing, and an NASC seal. Products hiding behind “proprietary blend” labels make it impossible to evaluate the dose.
Frequently asked questions
Is L-theanine safe for dogs?
Available canine studies report no serious adverse effects at standard supplement doses, and L-theanine does not produce sedation at typical dosing levels. Its drug interaction profile is more benign than CBD because it does not undergo extensive hepatic CYP450 metabolism. Long-term safety data in dogs are limited, however, and any dog on concurrent medications should be evaluated by a veterinarian before starting a new supplement.
How long does L-theanine take to work in dogs?
Human pharmacokinetic studies show L-theanine crosses the blood-brain barrier within approximately 30 to 60 minutes. Most veterinary product labels recommend administering it 30 to 60 minutes before an anticipated stressor, consistent with that absorption window. Canine-specific pharmacokinetic data have not been published, so this timing is extrapolated from human research and clinical experience.
Is L-theanine the same as alpha-casozepine?
No. L-theanine is a tea-derived amino acid that modulates glutamate signaling and promotes alpha brain wave activity. Alpha-casozepine is a milk-protein-derived peptide that binds to GABA-A receptor benzodiazepine sites, a distinct mechanism confirmed in a 2022 study using the antagonist flumazenil (Benoit et al., PMCID: PMC9182760). They are different compounds, from different sources, working through different pathways.
Evidence-informed guide
Pawsd guides are educational and not a substitute for veterinary advice. These pages draw from selected open-access peer-reviewed veterinary research, with full-text sources linked below.
Selected references
Chong X, Hou J, He HF. Food Sci Nutr. 2025;13(8):e70811. PMCID: PMC12351064. Comprehensive review of theanine mechanism, neuroprotection, and stress management.
Riemer S. Animals (Basel). 2023;13(23):3664. PMCID: PMC10705068. Practitioner-focused review covering L-theanine, pressure wraps, pheromones, and desensitization.
Benoit S et al. Nutrients. 2022;14(11):2212. PMCID: PMC9182760. Rat model confirming alpha-casozepine acts via GABA-A benzodiazepine sites.
Scandurra A et al. Animals (Basel). 2022;12(4):435. PMCID: PMC8868118. RCT of a calming nutraceutical blend in dogs.
Nicotra M, Iannitti T, Di Cerbo A. Vet Sci. 2025;12(10):964. PMCID: PMC12568156. Review of nutraceutical interventions for behavioral management in companion animals.
L-theanine is one ingredient. The right plan considers the whole picture.
Tell Scout about your dog's anxiety pattern, triggers, and what you've already tried. Scout will recommend specific products and strategies matched to your dog's situation.
Talk to Scout about your dog→Related Reading
Dog Calming Supplements: What the Evidence Can and Cannot Tell Us
CBD, calming blends, probiotics, melatonin, and botanicals. What current canine evidence can and cannot tell us, and where supplements may fit in a broader anxiety plan.
CBD for Dogs: What Current Veterinary Research Can and Cannot Tell Us
The evidence on CBD for dogs is mixed and still limited. What peer-reviewed research says about safety, efficacy, drug interactions, and quality — and how to opt out of CBD product recommendations.
Hemp vs CBD for Dogs: What's Actually in the Product and Why It Matters
Hemp seed oil and CBD oil come from the same plant but are chemically, legally, and functionally different. What peer-reviewed research and regulatory bodies say about each, and why the distinction matters for your dog.
Separation Anxiety in Dogs: Signs, Triggers, and Management
Separation-related distress can begin before you leave. How routine cues shape the pattern, how to distinguish it from boredom, and which management approaches are commonly used.
Products mentioned in this guide
This guide contains affiliate links. If you purchase through our links, we may earn a small commission at no cost to you.